- Rocca P., Marchiaro L., Cocuzza E., Bogetto F. Treatment of Borderline Personality Disorder with Risperidone. Journal of  Clinical Psychiatry 63: 241-244, 2002.

- Rocca P., Cocuzza E., Marchiaro L., Bogetto F. Donepezil in the treatment of Alzheimer's disease: Long-term efficacy and safety. Progress Neuropsychopharmacol Biol Psychiatry 26(2): 369-373, 2002.

- Rocca P., De Leo C., Eva C., Marchiaro L., Milani A., Musso R., Ravizza L., Zanalda E., Bogetto F.  Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with Major Depression. Progress Neuropsychopharmacol Biol Psychiatry 26: 1155-1160, 2002.

- Rocca P., Marchiaro L., Rasetti R., Rivoira E., Bogetto F.  A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes. Psychiatric Research 112: 145-152, 2002.

- Bellino S., Rocca P., Patria L., Marchiaro L., Rasetti R., Di Lorenzo R., Paradiso E., Bogetto F. Effects of age at onset on clinical features and cognitive functions of a sample of schizophrenic  patients. J Clin Psychiatry 65: 908-914, 2004.

- Paola Rocca, Paolo Calvarese, Fabrizio Faggiano, Livio Marchiaro, Federica Mathis, Elisa Rivoira, Barbara Taricco, Filippo Bogetto. Citalopram versus sertraline in late-life non-major clinically significant depression: a 1-year follow-up clinical trial. Journal of Clinical Psychiatry 66: 360-369, 2005.

- Rocca P., Bellino S., Calvarese P., Marchiaro L., Patria L., Rasetti R., Bogetto F. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry. 2005 Jul-Aug;46(4):304-10.

- Marchiaro L., Castagna F., Marino F., Rivoira E., Scalese M., Rocca P., Bogetto F. Minor depression and cognitive symptoms in elderly patients. The International Journal of Neuropsychopharmacology 7, Suppl. 1: S145-S146, 2004.

- Marchiaro L., Rocca P., LeNoci F., Longo P., Montemagni C., Rigazzi C., Bogetto F. Naturalistic, retrospective comparison between second generation antipsychotics and depot neuroleptics in patients affected by schizophrenia. J Clin Psychiatry. 2005 Nov;66(11):1423-31.

- Rocca P., Castagna F., Marchiaro L., Rasetti R., Rivoira E., Bogetto F. Neuropsychological correlates of reality distortion in paranoid and nonparanoid schizophrenic patients. Psychiatry Res. 2006 Nov 29;145(1):49-60.

- Nosè M, Accordini S, Artioli P, Barale F, Barbui C, Beneduce R, Berardi D, Bertolazzi G, Biancosino B, Bisogno A, Bivi R, Bogetto F, Boso M, Bozzani A, Bucolo P, Casale M, Cascone L, Ciammella L, Cicolini A, Cipresso G, Cipriani A, Colombo P, Dal Santo B, De Francesco M, Di Lorenzo G, Di Munzio W, Ducci G, Erlicher A, Esposito E, Ferrannini L, Ferrato F, Ferro A, Fragomeno N, Parise VF, Frova M, Gardellin F, Garzotto N, Giambartolomei A, Giupponi G, Grassi L, Grazian N, Grecu L, Guerrini G, Laddomada F, Lazzarin E, Lintas C, Malchiodi F, Malvini L, Marchiaro L, Marsilio A, Mauri MC, Mautone A, Menchetti M, Migliorini G, Mollica M, Moretti D, Mulè S, Nicholau S, Nosè F, Occhionero G, Pacilli AM, Pecchioli S, Percudani M, Piantato E, Piazza C, Pontarollo F, Pycha R, Quartesan R, Rillosi L, Risso F, Rizzo R, Rocca P, Roma S, Rossattini M, Rossi G, Rossi G, Sala A, Santilli C, Saraò G, Sarnicola A, Sartore F, Scarone S, Sciarma T, Siracusano A, Strizzolo S, Tansella M, Targa G, Tasser A, Tomasi R, Travaglini R, Veronese A, Ziero S. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combinatio with clozapine for treatment-resistant schizophrenia.Trials 15:10-31, 2009.

- Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A; CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. J Clin Psychopharmacol. 2011 Jun;31(3):266-73.